Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer
- PMID: 23269988
- PMCID: PMC3731921
- DOI: 10.1200/JCO.2012.44.1170
Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer
Abstract
Purpose: It is unclear why racial differences exist in the frequency of surgery for lung cancer treatment. Comorbidity is an important consideration in selection of patients for lung cancer treatment, including surgery. To assess whether comorbidity contributes to the observed racial differences, we evaluated racial differences in the prevalence of comorbidity and their impact on receipt of surgery.
Patients and methods: A total of 1,314 patients (1,135 white, 179 black) in the Veterans Health Administration diagnosed with early-stage non-small-cell lung cancer in 2007 were included. The effect of comorbidity on surgery was determined by using generalized linear models with a logit link accounting for patient clustering within Veterans Administration Medical Centers.
Results: Compared with whites, blacks had greater prevalence of hypertension, liver disease, renal disease, illicit drug abuse, and poor performance status, but lower prevalence of respiratory disease. The impact of most individual comorbidities on receipt of surgery was similar between blacks and whites, and comorbidity did not influence the race-surgery association in a multivariable analysis. The proportion of blacks not receiving surgery as well as refusing surgery was greater than that among whites.
Conclusion: Blacks had a greater prevalence of several comorbid conditions and poor performance status; however, the overall comorbidity score did not differ by race. In general, the effect of comorbidity on receipt of surgery was similar in blacks and whites. Racial differences in comorbidity do not fully explain why blacks undergo lung cancer surgery less often than whites.
Conflict of interest statement
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Figures
Similar articles
-
Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):112-118. doi: 10.1158/1055-9965.EPI-19-0245. Epub 2019 Oct 17. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31624076
-
Urban/rural patterns in receipt of treatment for non-small cell lung cancer among black and white Medicare beneficiaries, 2000-2003.J Natl Med Assoc. 2011 Aug;103(8):711-8. doi: 10.1016/s0027-9684(15)30410-7. J Natl Med Assoc. 2011. PMID: 22046848
-
Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina.Ann Thorac Surg. 2008 Jul;86(1):220-6; discussion 227. doi: 10.1016/j.athoracsur.2008.02.072. Ann Thorac Surg. 2008. PMID: 18573427 Free PMC article.
-
Contemporary review on the inequities in the management of lung cancer among the African-American population.J Natl Med Assoc. 2008 Jun;100(6):683-8. doi: 10.1016/s0027-9684(15)31342-0. J Natl Med Assoc. 2008. PMID: 18595570 Review.
-
Racial differences in lung cancer.Cancer Metastasis Rev. 2003 Mar;22(1):39-46. doi: 10.1023/a:1022207917249. Cancer Metastasis Rev. 2003. PMID: 12716035 Review.
Cited by
-
Racial/ethnic disparities in curative-intent treatment for early-stage non-small cell lung cancer patients among heterogeneous Black populations: US-born Black, Afro-Haitian, West Indian Black, and Hispanic Black.Cancer Med. 2024 Oct;13(19):e7449. doi: 10.1002/cam4.7449. Cancer Med. 2024. PMID: 39377643 Free PMC article.
-
Summary of Veterans Health Administration Cancer Data Sources.J Registry Manag. 2024 Spring;51(1):21-28. J Registry Manag. 2024. PMID: 38881982 Free PMC article.
-
A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US.Front Genet. 2023 Apr 4;14:1141058. doi: 10.3389/fgene.2023.1141058. eCollection 2023. Front Genet. 2023. PMID: 37082203 Free PMC article.
-
Rural-Urban Disparities in Receipt of Surgery for Potentially Resectable Non-Small Cell Lung Cancer.J Surg Res. 2023 Mar;283:1053-1063. doi: 10.1016/j.jss.2022.10.097. Epub 2022 Dec 14. J Surg Res. 2023. PMID: 36914996 Free PMC article.
-
Comorbidities and ethnic health disparities in the UK biobank.JAMIA Open. 2022 Jul 11;5(3):ooac057. doi: 10.1093/jamiaopen/ooac057. eCollection 2022 Oct. JAMIA Open. 2022. PMID: 36313969 Free PMC article.
References
-
- Scott WJ, Howington J, Feigenberg S, et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines. Chest. (2nd edition) 2007;132:234S–242S. - PubMed
-
- Beckles MA, Spiro SG, Colice GL, et al. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest. 2003;123:105S–114S. - PubMed
-
- de Rijke JM, Schouten LJ, ten Velde GP, et al. Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer: Results of a population-based study. Lung Cancer. 2004;46:233–245. - PubMed
-
- Tammemagi CM, Neslund-Dudas C, Simoff M, et al. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol. 2004;57:597–609. - PubMed
-
- Janssen-Heijnen ML, Schipper RM, Razenberg PP, et al. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: A population-based study. Lung Cancer. 1998;21:105–113. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
